CA057-1070-EAP: Expanded Access Program for Mezigdomide (in combination with Carfilzomib/dex or Bortezomib/dex) For Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
- Title
- Expanded Access Program for Mezigdomide (in combination with Carfilzomib/dex or Bortezomib/dex) For Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
- Principal Investigator
- Veltri, Lauren
- Phase
- NA
- Age Group
- Adult
- Applicable Disease Sites
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Syed Abdul Mannan Shah
- Clinical Research Specialist
- Phone: +1 304-293-1683
- Email: syedabdulmannan.shah@hsc.wvu.edu